CannaGrow Bioscience: A Technology for Healthcare Industry

Cannabis has been legalized in several states for a few years now and it is followed by other countries outside the USA. The growth of cannabis is predicted to be USD 20bn in 2022 by the CBD. The CBD itself is a nutraceutical based on the UK that makes a cake named CannaGrow Biosciences or CGBs,

This organization is actively promoting advantages once the cannabis has been legalized around the world especially when they name the product “Reverse Nature”. They work on three products and those three are currently on their testing and trial stage before officially being used with the name of nutraceutical, while all of them are using cannabis as their basic ingredients.

The customer reviews on the website of Reverse Nature™ show that this brand will surely give anyone what they want. This reputation has been basically achieved effortlessly, especially when Reverse Nature™ puts themselves at the high-end market across Europe and the UK. Once the product reaches the cannabis market in the US, anything they need is only the time when it comes to becoming the global distributor of cannabis products.

Considering CGBs have the potential to develop the nutraceutical and healthcare industries, the spirit and excitements that accompany the products would be pretty proliferating. Today, there are several products on the market people would buy to treat a certain condition. Terperderm™ as a topical drug for eczema and psoriasis and Revernat™ to treat PTSD and anxiety are just two of many prescribed drugs you may find. Still, people would be more excited about Tinatate that is targeted to treat Tinnitus. Tinnitus is a condition that affects one’s social life which could cause depression and even tendencies to do suicidal actions. According to the data, this condition affects more than 15 percent of the human population in the world. By promoting such a product like Reverse Nature™, this would be a huge revolutionary movement.

The official trials of Tinatate would be started in June 2019 and August will be the month where the results are ready. The indications for Tinatate looks pretty promising judging from its pitch rate reduction from 7/8 to ¾. The initial results have also shown that it could establish the trust of those who suffer from Tinnitus in CBGs, considering some of them are also financially supporting and funding these trails.

With all these great news and developments for transforming the scene of healthcare worldwide, CannaGrow Biosciences has become one thing to keep an eye out for nutraceutical and health industries.